Subscribe

Thomas E. Hutson, DO, PharmD

Articles by Thomas E. Hutson, DO, PharmD

Dr. Hutson on Challenges With Targeted Therapy in Non-Clear Cell RCC

ByThomas E. Hutson, DO, PharmD

January 8th 2021

Thomas Hutson, DO, PharmD, discusses challenges with targeted therapy in non-clear cell renal cell carcinoma.

Latest Updated Articles

Dr. Hutson on Challenges With Targeted Therapy in Non-Clear Cell RCC
Published: January 8th 2021 | Updated:

Trending on CGTlive®

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

CGTLive®’s Weekly Rewind – October 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.